Shinichi Maruyama
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Therapeutic Drug Monitoring in a Patient with Metastatic Renal Cell Carcinoma Who Achieved Long-Term Response to Cabozantinib in Third-Line Treatment: A Case Report.
Journal: Case reports in oncology
Published: November 23, 2024
The significance of therapeutic drug monitoring in detecting low medication adherence in patients with cancer: A case study of cabozantinib.
Journal: Clinical case reports
Published: June 01, 2024
Association of Plasma Cabozantinib Concentration With Treatment Response and Adverse Events in Japanese Patients With Advanced Renal Cell Carcinoma.
Journal: Therapeutic drug monitoring
Published: April 06, 2024
Preliminary Investigation of a Rapid and Feasible Therapeutic Drug Monitoring Method for the Real-Time Estimation of Blood Pazopanib Concentrations.
Journal: The AAPS journal
Published: January 03, 2024
MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system.
Journal: Frontiers in plant science
Published: November 22, 2023
Quantitative determination of plasma cabozantinib concentration using HPLC-UV and its application to patients with renal cell carcinoma.
Journal: Biomedical chromatography : BMC
Published: December 24, 2022
Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
Journal: Vaccine
Published: November 09, 2021
Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine.
Journal: BMC genomics
Published: April 29, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026